Enter inventor name

Helmut Fiebig

This inventor holds 22 USPTO granted patents and 4 published patent applications and 8 EPO patents. Top assignees: Merck Patent Gmbh, Merck Patent Gesellschaft MIT Beschrankter Haftung. Active years: 2007-2018.

USPTO Granted Patents = 22 (Patent Applications = 4)

EPO Patents = 8 (Patent Applications = 3)

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 5(Granted Patents)

Location History:

Schwarzenbeck, DE (2011)
Schwarzenbek, DE (2007 - 2018)

Company Filing History:

Merck Patent Gesellschaft MIT Beschrankter Haftung

patents

Years Active: 2007-2018

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9975932 - Variants of group 5 allergens of the true grasses having reduced allergeneity due to mutagenesis of proline residues (2018-05-22),

2. 9789178 - DNA sequence, and recombinant preparation of the grass pollen allergen Lol p 4 (2017-10-17),

3. 9556241 - DNA sequence and preparation of grass pollen allergen Phl p 4 by recombinant methods (2017-01-31),

4. 9522938 - Phl p 5a derivatives having reduced allergeneity and retained T-cell reactivity (2016-12-20),

5. 9453058 - Variants of the major allergen Phl P 1 from timothy grass (2016-09-27),

6. 9441021 - Process for the preparation of hypoallergenic major birch pollen allergen rBet v 1 (2016-09-13),

7. 9309297 - DNA sequence, and recombinant preparation of group 4 major allergens from cereals (2016-04-12),

8. 9120866 - DNA sequence and preparation of grass pollen allergen Phl p 4 by recombinant methods (2015-09-01),

9. 8999348 - Variants of group 6 allergens of the true grasses having reduced allergeneity due to mutagenesis of proline residues (2015-04-07),

10. 8945530 - DNA sequence, and recombinant preparation of the grass pollen allergen Lol p4 (2015-02-03),

11. 8628946 - Phl p 5a derivatives having reduced allergeneity and retained T-cell reactivity (2014-01-14),

12. 8420097 - DNA sequence, and recombinant preparation of the grass pollen allergen Lol p 4 (2013-04-16),

13. 8329185 - Method for isolating and purifying grass pollen allergens (2012-12-11),

14. 8263090 - [object Object] (2012-09-11),

15. 8128935 - DNA sequence and recombinant production of the grass pollen allergen Phl p 4 (2012-03-06),

Title: Innovations in Allergy Research: The Patents of Helmut Fiebig

Introduction

Helmut Fiebig, an accomplished inventor based in Schwarzenbek, Germany, holds an impressive portfolio of 22 patents. His work predominantly focuses on the development of novel allergen variants and innovative therapeutic solutions for pollen allergies. Through his research, he has significantly contributed to the field of allergology, aiming to improve the quality of life for those affected by allergies.

Latest Patents

Fiebig’s latest patents include groundbreaking inventions such as "Variants of Group 5 Allergens of the True Grasses Having Reduced Allergenicity Due to Mutagenesis of Proline Residues." This invention presents recombinant variants of group 5 allergens of the Poaceae family, characterized by diminished IgE reactivity while retaining reactivity with T-lymphocytes. Additionally, he has patented a significant invention titled "DNA Sequence and Recombinant Preparation of the Grass Pollen Allergen Lol p 4." This patent encompasses the isolation of the DNA sequence for Lol p 4 and introduces fragments, new combinations, and variants that display hypoallergenic properties. Furthermore, the recombinant DNA molecules and derived polypeptides aim to assist in the therapy and diagnosis of pollen-allergic diseases.

Career Highlights

Fiebig has garnered extensive experience during his career, notably working with prestigious organizations such as Merck Patent GmbH and Merck Patent Gesellschaft mit beschränkter Haftung. His contributions to these companies have positioned him as a leading innovator in the realm of allergen research.

Collaborations

Throughout his career, Fiebig has collaborated with notable colleagues, including Oliver Cromwell and Andreas Nandy. These partnerships have fostered an environment of shared knowledge and innovation, ultimately enhancing the research and development of therapeutic solutions for allergy sufferers.

Conclusion

Helmut Fiebig's dedication to exploring and innovating in the field of allergology is evident through his numerous patents and collaborations. His work continues to pave the way for advancements in allergy treatment and diagnosis, contributing significantly to the health and well-being of individuals affected by pollen allergies.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]